Varex Imaging (NASDAQ:VREX) Given “Neutral” Rating at Sidoti

Varex Imaging (NASDAQ:VREX)‘s stock had its “neutral” rating reiterated by investment analysts at Sidoti in a research report issued on Monday,Benzinga reports. They currently have a $19.00 price target on the stock. Sidoti’s price target would indicate a potential upside of 53.10% from the stock’s previous close.

A number of other equities research analysts have also commented on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a research report on Wednesday, June 24th. Wall Street Zen raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research report on Saturday, July 4th. Finally, Zacks Research downgraded Varex Imaging from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 27th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $16.88.

Varex Imaging Stock Performance

NASDAQ VREX opened at $12.41 on Monday. The company has a quick ratio of 1.43, a current ratio of 3.20 and a debt-to-equity ratio of 0.67. Varex Imaging has a 52 week low of $8.42 and a 52 week high of $14.56. The business has a 50 day moving average price of $10.77 and a 200-day moving average price of $11.51. The company has a market cap of $522.46 million, a price-to-earnings ratio of -6.21 and a beta of 0.89.

Varex Imaging (NASDAQ:VREX) last released its quarterly earnings data on Monday, August 10th. The company reported $0.31 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.10. Varex Imaging had a negative net margin of 9.64% and a positive return on equity of 8.19%. The firm had revenue of $210.50 million for the quarter, compared to analyst estimates of $215.50 million. As a group, equities analysts expect that Varex Imaging will post 0.93 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Varex Imaging

Hedge funds have recently modified their holdings of the stock. Rockefeller Capital Management L.P. purchased a new position in Varex Imaging in the fourth quarter valued at approximately $27,000. Quarry LP purchased a new stake in Varex Imaging in the 3rd quarter worth about $64,000. BNP Paribas Financial Markets lifted its holdings in Varex Imaging by 18.5% during the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after purchasing an additional 2,036 shares during the last quarter. Aquatic Capital Management LLC bought a new position in Varex Imaging during the third quarter worth about $117,000. Finally, Cerity Partners LLC bought a new stake in shares of Varex Imaging in the second quarter valued at approximately $123,000.

Varex Imaging News Summary

Here are the key news stories impacting Varex Imaging this week:

• Positive Sentiment: Teledyne takeover provides a significant valuation catalyst. Teledyne will pay $18.90 per Varex share, subject to customary closing conditions and approvals. The offer represents a substantial premium to Varex’s recent trading level, giving investors a clearly defined cash exit value. Teledyne to acquire Varex Imaging in $1.1 billion deal
• Positive Sentiment: Varex delivered an earnings beat on profit. Quarterly earnings per share exceeded the analyst consensus estimate of $0.21, with the company reporting $15.7 million of attributable net income and $21 million in operating cash flow. Varex Imaging earnings results
• Neutral Sentiment: Revenue growth remained modest but positive. Fiscal third-quarter revenue was $210.5 million, up 4% year over year, including $134.0 million from Medical and $76.5 million from Industrial. The company also reported a 36.4% GAAP gross margin and $99 million in cash, cash equivalents and marketable securities. Varex Announces Financial Results for Third Quarter Fiscal Year 2026
• Negative Sentiment: Revenue fell short of expectations and the company withdrew normal investor communication. Revenue missed the approximately $215.5 million consensus estimate. Varex canceled its earnings conference call and will not provide financial guidance because of the Teledyne transaction, reducing visibility into standalone operating prospects. The quarter also included a $7 million reduction to revenue for expected customer reimbursements, partly offset by a $17 million U.S. Customs tariff refund.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.